youtube_live
Q3 2026 earnings • released • EPS beat +8.62% • Revenue beat +2.31%
See resultschevron_right
EW:NYSE
Edwards Lifesciences Corp
$101.48
arrow_upward
+0.69%(+0.70) 1D
Nov 6, 2:36:51 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$99.00
High
$101.85
Low
$98.50
Mkt. cap
58.37B
Avg. vol.
4.32M
Volume
2.02M
P/E ratio
57.41
52-wk high
$104.16
52-wk low
$74.66
EPS
$1.76
Beta
0.85
Shares outstanding
575.00M
No. of employees
16K
Open
$99.00
High
$101.85
Low
$98.50
Mkt. cap
58.37B
Avg. vol.
4.32M
Volume
2.02M
P/E ratio
57.41
52-wk high
$104.16
52-wk low
$74.66
EPS
$1.76
Beta
0.85
Shares outstanding
575.00M
No. of employees
16K
News stories
From web sources and news partners
Zacks
·
3 hours ago
HIMS' Q3 Earnings: Can Weight Loss Momentum Drive Performance?
Trefis
·
9 hours ago
Is Edwards Lifesciences Stock Really Expensive?
TradingView
·
11 hours ago
Key facts: EW beats, lifts view; TAVR meets goals; stock hits 2022 high
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorHealth Care
IndustryMedical device
Websiteedwards.com